The impact of MECP2 mutations in the expression patterns of Rett syndrome patients

Human Genetics

Volumn 116, Issue 1-2, 2005, Pages 91-104

  Ballestar, Esteban ^a   Ropero, Santiago ^a   Alaminos, Miguel ^a   Armstrong, Judith ^b   Setien, Fernando ^a   Agrelo, Ruben ^a   Fraga, Mario F ^a   Herranz, Michel ^a   Avila, Sonia ^a   Pineda, Mercedes ^c   Monros, Eugenia ^b   Esteller, Manel ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; COMPLEMENTARY DNA; DNA; METHYL CPG BINDING PROTEIN 2;

ARTICLE; CHROMATIN; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; FEMALE; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPHOBLASTOID CELL; NERVE CELL; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; RETT SYNDROME;

BLOTTING, WESTERN; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MUTATION; REPRESSOR PROTEINS; RETT SYNDROME;

EID: 19944426483     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-004-1200-0     Document Type: Article

References (55)

1. Alaminos M, Mora J, Cheung NK, Smith A, Qin J, Chen L, Gerald WL (2003) Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 63:4538-4546
2. Allan DW, Thor S (2003) Together at last: BHLH and LIM-HD regulators cooperate to specify motor neurons. Neuron 38:675-677
3. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW (1992) Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239
4. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MeCP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188
5. Armstrong DD (1997) Review of Rett syndrome. J Neuropathol Exp Neurol 56:843-849
6. Ballestar E, Yusufzai TM, Wolffe AP (2000) Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 20:7100-7106
7. Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, Espada J, Cigudosa JC, Huang THM, Esteller M (2003) Methyl-CpG binding proteins identify novel sites of epigenetic activation in human cancer. EMBO J 22:6335-6345
8. Bazan NG, Palacios-Pelaez R, Lukiw WJ (2002) Hypoxia signaling to genes: significance in Alzheimer's disease. Mol Neurobiol 26:269-281
9. Bird A, Tweedie S (1995) Transcriptional noise and the evolution of gene number. Philos Trans R Soc Lond B Biol Sci 349:249-253
10. Buschdorf JP, Stratling WH (2004) A WW domain binding region in methyl-CpG-binding protein MeCP2: Impact on Rett syndrome. J Mol Med 82:135-143
11. Caruana G (2002) Genetic studies define MAGUK proteins as regulators of epithelial cell polarity. Int J Dev Biol 46:511-518
12. Chan AM, Takai S, Yamada K, Miki T (1996) Isolation of a novel oncogene, NET1 , from neuroepithelioma cells by expression cDNA cloning. Oncogene 12:1259-1266
13. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885-889
14. Clark SJ, Warnecke PM (2002) DNA methylation analysis in mammalian cells. Methods 27:99-100
15. Cobb J, Miyaike M, Kikuchi A, Handel MA (1999) Meiotic events at the centromeric heterochromatin: Histone H3 phosphorylation, topoisomerase II alpha localization and chromosome condensation. Chromosoma 108:412-425
16. Colantuoni C, Jeon OH, Hyder K, Chenchik A, Khimani AH, Narayanan V, Hoffman EP, Kaufmann WE, Naidu S, Pevsner J (2001) Gene expression profiling in postmortem Rett sndrome brain: Differential gene expression and patient classification. Neurobiol Dis 8:847-865
17. Dopazo J, Dopazo JM (1997) Phylogenetic reconstruction using an unsupervised growing neural network that adopts the topology of a phylogenetic tree. J Mol Evol 44:226-233
18. Esteller M (2000) Epigenetic lesions causing genetic lesions in human cancer: Promoter hypermethylation of DNA repair genes. Eur J Cancer 36:2294-2300
19. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 21:5427-5440
20. Fournier C, Goto Y, Ballestar E, Delaval K, Hever A, Esteller M, Feil R (2002) Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J 21:6560-6570
21. Fraga MF, Esteller M (2002) DNA methylation: A profile of methods and applications. Biotechniques 33:632-649
22. Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M (2003) The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 31:1765-1774
23. Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, Hansen JC (2003) Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 278:32181-32188
24. Herrero J, Diaz-Uriarte R, Dopazo J (2003) Gene expression data preprocessing. Bioinformatics 19:655-656
25. Hescheler J, Schultz G (1994) Heterotrimeric G proteins involved in the modulation of voltage-dependent calcium channels of neuroendocrine cells. Ann N Y Acad Sci 733:306-312
26. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191
27. Kempkes B, Pich D, Zeidler R, Hammerschmidt W (1995) Immortalization of human primary B lymphocytes in vitro with DNA. Proc Natl Acad Sci USA 92:5875-5879
28. Koizume S, Tachibana K, Sekiya T, Hirohashi S, Shiraishi M (2002) Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res 30:4770-4780
29. Kriaucionis S, Bird A (2003) DNA methylation and Rett syndrome. Hum Mol Genet 12 (Spec 2):R221-R227
30. Laccone F, Junemann I, Whatley S, Morgan R, Butler R, Huppke P, Ravine D (2004) Large deletions of the MeCP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum Mutat 23:234-244
31. Lang AJ, Mirski SE, Cummings HJ, Yu Q, Gerlach JH, Cole SP (1998) Structural organization of the human TOP2A and TOP2B genes. Gene 221:255-266
32. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890-893
33. Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ, Jones JR, Scherer SW, Schanen NC, Friez MJ, Vincent JB, Minassian BA (2004) A previously unidentified MeCP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36:339-341
34. Monros E, Armstrong J, Aibar E, Poo P, Canos I, Pineda M (2001) Rett syndrome in Spain: Mutation analysis and clinical correlations. Brain Dev 23 (Suppl 1):S251-S253
35. Moreno-Bueno G, Sanchez-Estevez C, Cassia R, Rodriguez-Perales S, Diaz-Uriarte R, Dominguez O, Hardisson D, Andujar M, Prat J, Matias-Guiu X, Cigudosa JC, Palacios J (2003) Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res 63:5697-5702
36. Nan X, Bird A (2001) The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome. Brain Dev 23 (Suppl 1):S32-S37
37. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389
38. Nguyen CT, Gonzales FA, Jones PA (2001) Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 29:4598-4606
39. Orlando V (2000) Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem Sci 25:99-104
40. Reik W, Constancia M, Dean W, Davies K, Bowden L, Murrell A, Feil R, Walter J, Kelsey G (2000) Igf2 imprinting in development and disease. Int J Dev Biol 44:145-150
41. Schmidt JT, Morgan P, Dowell N, Leu B (2002) Myosin light chain phosphorylation and growth cone motility. J Neurobiol 52:175-188
42. Schraven B, Schoenhaut D, Bruyns E, Koretzky G, Eckerskorn C, Wallich R, Kirchgessner H, Sakorafas P, Labkovsky B, Ratnofsky S et al (1994) LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J Biol Chem 269:29102-29111
43. Stancheva I, Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR (2003) A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by Notch in Xenopus embryos. Mol Cell 12:425-432
44. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF et al (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99:16899-16903
45. Sugie H, Sugie Y, Tsurui S, Ito M (1994) Phosphoglycerate kinase deficiency. Neurology 44:1364-1365
46. Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, Rodriguez-Peralto JL, Fernandez-Herrera J et al (2002) Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 161:1825-1837
47. Traynor J, Agarwal P, Lazzeroni L, Francke U (2002) Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MeCP2 mutations. BMC Med Genet 3:12
48. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB (2001) Missing value estimation methods for DNA microarrays. Bioinformatics 17:520-525
49. Tudor M, Akbarian S, Chen RZ, Jaenisch R (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 99:5536-5541
50. Tusher V, Tibshirani R, Chu C (2001) Significance analysis of microarrays applied to ionising radiation response. Proc Natl Acad Sci USA 98:5116-5121
51. Vacca M, Filippini F, Budillon A, Rossi V, Della Ragione F, De Bonis ML, Mercadante G, Manzati E, Gualandi F, Bigoni S, Trabanelli C, Pini G, Calzolari E, Ferlini A, Meloni I, Hayek G, Zappella M, Renieri A, D'Urso M, D'Esposito M, Macdonald F, Kerr A, Dhanjal S, Hulten M (2001) MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: Hot spot map of the most recurrent mutations and bioinformatic analysis of a new MeCP2 conserved region. Brain Dev 23 (Suppl 1): S246-S250
52. Van den Veyver IB, Zoghbi HY (2000) Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr Opin Genet Dev 10:275-279
53. Webb T, Latif F (2001) Rett syndrome and the MECP2 gene. J Med Genet 38:217-223
54. Willard H, Hendrich BD (1999) Breaking the silence in Rett syndrome. Nat Genet 23:127-128
55. Yusufzai TM, Wolffe AP (2000) Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28:4172-4179